The U.S. Food and Drug Administration (FDA) will prohibit the use of a class of antimicrobial drugs in livestock, citing concerns that overuse of the drugs could promote the development of antibiotic-resistant pathogens that could infect humans. Beginning April 5, the FDA will limit the use of cephalosporin in cattle, swine, chickens and turkeys, allowing the antibiotic to be used to treat illness but not for disease prevention. Studies have linked the prevalent use of such drugs in livestock — mainly to prevent disease and promote weight gain — to the creation of disease-resistant “superbugs” that can spread to humans. In 2008, the FDA banned the use of cephalosporin for livestock, but withdrew the plan after industry opposition. The new proposal will allow exceptions, including approved limited doses when prescribed or administered by veterinarians. While public health advocates supported the FDA decision, they say it deals with just one aspect of the use of antibiotics in animals and does not address the use of antibiotics in animal feed.
U.S. Limits Antibiotics Use In Livestock to Prevent ‘Superbugs’
More From E360
-
Biodiversity
Older and Wiser: How Elder Animals Help Species to Survive
-
Climate
Rusting Rivers: Alarm Grows Over Uptick in Acidic Arctic Waters
-
ANALYSIS
A More Troubling Picture of Sea Level Rise Is Coming into View
-
INTERVIEW
Why Protecting Flowering Plants Is Crucial to Our Future
-
OPINION
Trying Times: Keeping the Faith as Environmental Gains Are Lost
-
ANALYSIS
As It Boosts Renewables, China Still Can’t Break Its Coal Addiction
-
OPINION
Can America’s Wolves Survive an Onslaught of Political Attacks?
-
MINING
As Zambia Pushes New Mining, a Legacy of Pollution Looms
-
Biodiversity
Long Overlooked as Crucial to Life, Fungi Start to Get Their Due
-
ANALYSIS
Species Slowdown: Is Nature’s Ability to Self-Repair Stalling?
-
OPINION
Beyond ‘Endangerment’: Finding a Way Forward for U.S. on Climate
-
Solutions
The E.U.’s Burgeoning Repair Movement Is Set to Get a Boost